Alan T. Nurden

Pessac-sur-dordogne, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 99 publications

Platelet-derived integrin- and tetraspanin-enriched tethers exacerbate severe inflammation.

Platelet-derived integrin- and tetraspanin-enriched tethers exacerbate severe inflammation.

Journal: Science (New York, N.Y.)
Published: January 22, 2026

Reduced platelet formation associated with serine metabolic dysregulation in integrin αIIbβ3-deficient megakaryocytes.

Reduced platelet formation associated with serine metabolic dysregulation in integrin αIIbβ3-deficient megakaryocytes.

Journal: Blood
Published: October 01, 2025

Glanzmann Thrombasthenia 10 Years Later: Progress Made and Future Directions.

Glanzmann Thrombasthenia 10 Years Later: Progress Made and Future Directions.

Journal: Seminars in thrombosis and hemostasis
Published: March 18, 2024

The GPIIb-IIIa defect of platelets in Glanzmann thrombasthenia.

The GPIIb-IIIa defect of platelets in Glanzmann thrombasthenia.

Journal: Haematologica
Published: April 01, 2023

A single F153Sβ3 mutation causes constitutive integrin αIIbβ3 activation in a variant form of Glanzmann thrombasthenia.

A single F153Sβ3 mutation causes constitutive integrin αIIbβ3 activation in a variant form of Glanzmann thrombasthenia.

Journal: Blood advances
Published: December 06, 2022

Molecular basis of clot retraction and its role in wound healing.

Molecular basis of clot retraction and its role in wound healing.

Journal: Thrombosis research
Published: June 06, 2022

APOLD1 loss causes endothelial dysfunction involving cell junctions, cytoskeletal architecture, and Weibel-Palade bodies, while disrupting hemostasis.

APOLD1 loss causes endothelial dysfunction involving cell junctions, cytoskeletal architecture, and Weibel-Palade bodies, while disrupting hemostasis.

Journal: Haematologica
Published: May 27, 2022

Healing through the lens of immunothrombosis: Biology-inspired, evolution-tailored, and human-engineered biomimetic therapies.

Healing through the lens of immunothrombosis: Biology-inspired, evolution-tailored, and human-engineered biomimetic therapies.

Journal: Biomaterials
Published: June 17, 2021

Profiling the Genetic and Molecular Characteristics of Glanzmann Thrombasthenia: Can It Guide Current and Future Therapies?

Profiling the Genetic and Molecular Characteristics of Glanzmann Thrombasthenia: Can It Guide Current and Future Therapies?

Journal: Journal of blood medicine
Published: May 05, 2021

Inherited platelet diseases with normal platelet count: phenotypes, genotypes and diagnostic strategy.

Inherited platelet diseases with normal platelet count: phenotypes, genotypes and diagnostic strategy.

Journal: Haematologica
Published: June 13, 2020

More than 500 million years of evolution in a fibrin-based therapeutic scaffold.

More than 500 million years of evolution in a fibrin-based therapeutic scaffold.

Journal: Regenerative medicine
Published: May 23, 2020

Inherited thrombocytopenias: history, advances and perspectives.

Inherited thrombocytopenias: history, advances and perspectives.

Journal: Haematologica
Published: April 23, 2020
Showing 1-12 of 99

Last Updated: 09/26/2026